Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus

NCT00752999 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was withdrawn for business reasons before study start.

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Fostamatinib Disodium (R935788)
DRUG: Placebo

Sponsor

Rigel Pharmaceuticals